📊 DH Key Takeaways
Investment Thesis
Despite strong gross margins of 75.9% and positive free cash flow of $37.1M, Definitive Healthcare is unprofitable with significant operating losses (-$224.3M) and negative net income (-$138.9M), indicating operational inefficiency and value destruction. Revenue declined 4.2% YoY while losses persist, suggesting fundamental business model challenges that cash reserves and FCF generation cannot offset.
DH Strengths
- Strong gross margin of 75.9% demonstrates pricing power and customer value in healthcare software
- Positive free cash flow of $37.1M with healthy 15.3% FCF margin despite operating losses
- Solid balance sheet with $163.6M cash and manageable debt-to-equity ratio of 0.44x provides financial stability
DH Risks
- Severe operating losses of -$224.3M with -92.9% operating margin indicating fundamental unprofitability despite high gross margins
- Revenue decline of 4.2% YoY combined with deteriorating net losses represents declining business momentum and market traction
- Negative interest coverage of -19.9x cannot sustain debt service long-term; company burning cash operationally despite FCF mask
Key Metrics to Watch
- Revenue growth trajectory and return to positive growth
- Operating margin improvement path to profitability
- Operating cash flow sustainability as operating losses may eventually reverse FCF generation
DH Financial Metrics
💡 AI Analyst Insight
Definitive Healthcare Corp. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
DH Profitability Ratios
DH vs Technology Sector
How Definitive Healthcare Corp. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
DH Balance Sheet & Liquidity
DH 5-Year Financial Trend
5-Year Trend Summary: Definitive Healthcare Corp.'s revenue has grown significantly by 52% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.79 indicates the company is currently unprofitable.
DH Growth Metrics (YoY)
DH Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $60.0M | -$14.8M | $-0.14 |
| Q2 2025 | $60.8M | -$7.6M | $-0.07 |
| Q1 2025 | $59.2M | -$9.5M | $-0.08 |
| Q3 2024 | $62.7M | -$130.9M | $-1.12 |
| Q2 2024 | $61.0M | -$8.6M | $-0.08 |
| Q1 2024 | $59.2M | -$9.5M | $-0.08 |
| Q3 2023 | $57.4M | -$3.0M | $-0.03 |
| Q2 2023 | $54.5M | -$5.5M | $-0.06 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
DH Capital Allocation
DH SEC Filings
Access official SEC EDGAR filings for Definitive Healthcare Corp. (CIK: 0001861795)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DH
What is the AI rating for DH?
Definitive Healthcare Corp. (DH) has an AI rating of SELL with 82% confidence, based on fundamental analysis of SEC EDGAR filings.
What are DH's key strengths?
Claude: Strong gross margin of 75.9% demonstrates pricing power and customer value in healthcare software. Positive free cash flow of $37.1M with healthy 15.3% FCF margin despite operating losses.
What are the risks of investing in DH?
Claude: Severe operating losses of -$224.3M with -92.9% operating margin indicating fundamental unprofitability despite high gross margins. Revenue decline of 4.2% YoY combined with deteriorating net losses represents declining business momentum and market traction.
What is DH's revenue and growth?
Definitive Healthcare Corp. reported revenue of $241.5M.
Does DH pay dividends?
Definitive Healthcare Corp. does not currently pay dividends.
Where can I find DH SEC filings?
Official SEC filings for Definitive Healthcare Corp. (CIK: 0001861795) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DH's EPS?
Definitive Healthcare Corp. has a diluted EPS of $-1.30.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.